146 related articles for article (PubMed ID: 17599946)
1. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population.
Zhu ZZ; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu G
Jpn J Clin Oncol; 2007 May; 37(5):385-90. PubMed ID: 17599946
[TBL] [Abstract][Full Text] [Related]
2. [TP53 gene polymorphisms and colorectal cancer risk in Chinese population].
Jia HR; He XL; Zhu ZZ; Jin XX; Wang AZ; Huang HY; Zhu J; Yu GB; Zhu GS
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1448-51. PubMed ID: 17785079
[TBL] [Abstract][Full Text] [Related]
3. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
4. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
5. TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Joshi AM; Budhathoki S; Ohnaka K; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y
Jpn J Clin Oncol; 2011 Feb; 41(2):232-8. PubMed ID: 21051533
[TBL] [Abstract][Full Text] [Related]
6. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
7. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.
Godai TI; Suda T; Sugano N; Tsuchida K; Shiozawa M; Sekiguchi H; Sekiyama A; Yoshihara M; Matsukuma S; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Miyagi Y
BMC Cancer; 2009 Dec; 9():420. PubMed ID: 19954513
[TBL] [Abstract][Full Text] [Related]
8. [Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Zhu GS; Liu SF; Xian ZH; Wu WQ; Zhang XZ; Wang YH; Wu MC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):632-5. PubMed ID: 16331559
[TBL] [Abstract][Full Text] [Related]
9. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Int J Cancer; 2006 May; 118(10):2479-84. PubMed ID: 16353134
[TBL] [Abstract][Full Text] [Related]
10. The p53 codon 72 polymorphism and the risk of oral cancer in a Chinese Han population.
Jing G; Lv K; Jiao X
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1149-52. PubMed ID: 22856646
[TBL] [Abstract][Full Text] [Related]
11. [Role of the genetic polymorphism of p53 (codon 72) gene in colorectal cancer].
Lima JM; Serafim PV; Silva ID; Forones NM
Arq Gastroenterol; 2006; 43(1):8-13. PubMed ID: 16699611
[TBL] [Abstract][Full Text] [Related]
12. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.
Zhu ZZ; Liu B; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu GS
J Zhejiang Univ Sci B; 2008 Nov; 9(11):847-52. PubMed ID: 18988302
[TBL] [Abstract][Full Text] [Related]
13. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
14. The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients.
Cao Z; Song JH; Park YK; Maeng EJ; Nam SW; Lee JY; Park WS
Neoplasma; 2009; 56(2):114-8. PubMed ID: 19239324
[TBL] [Abstract][Full Text] [Related]
15. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
[TBL] [Abstract][Full Text] [Related]
16. [Association between HRE-2 gene polymorphism at codon 655 and genetic susceptibility of colorectal cancer].
Liang X; Zhang YJ; Liu B; Ni Q; Jin MJ; Ma XY; Yao KY; Li QL; Chen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):302-5. PubMed ID: 19504444
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina.
Pérez LO; Abba MC; Dulout FN; Golijow CD
World J Gastroenterol; 2006 Mar; 12(9):1426-9. PubMed ID: 16552814
[TBL] [Abstract][Full Text] [Related]
18. Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Wang Y; Kringen P; Kristensen GB; Holm R; Baekelandt MM; Olivier M; Skomedal H; Hainaut P; Tropé CG; Abeler VM; Nesland JM; Børresen-Dale AL; Helland A
Hum Mutat; 2004 Jul; 24(1):21-34. PubMed ID: 15221786
[TBL] [Abstract][Full Text] [Related]
19. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
20. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.
De Oliveira LP; López I; Dos Santos EM; Tucci P; Marín M; Soares FA; Rossi BM; Coudry Rde A
Oncol Rep; 2014 Mar; 31(3):1396-406. PubMed ID: 24366026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
